These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 15626454
1. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pluta RM. Pharmacol Ther; 2005 Jan; 105(1):23-56. PubMed ID: 15626454 [Abstract] [Full Text] [Related]
2. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Pluta RM. Neurol Res; 2006 Oct; 28(7):730-7. PubMed ID: 17164036 [Abstract] [Full Text] [Related]
3. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Pluta RM. Acta Neurochir Suppl; 2008 Oct; 104():139-47. PubMed ID: 18456999 [Abstract] [Full Text] [Related]
4. Analysis of nitric oxide (NO) in cerebral vasospasm after aneursymal bleeding. Pluta RM, Oldfield EH. Rev Recent Clin Trials; 2007 Jan; 2(1):59-67. PubMed ID: 18473989 [Abstract] [Full Text] [Related]
7. In vitro and in vivo effects of probucol on hydrolysis of asymmetric dimethyl L-arginine and vasospasm in primates. Pluta RM, Jung CS, Harvey-White J, Whitehead A, Shilad S, Espey MG, Oldfield EH. J Neurosurg; 2005 Oct; 103(4):731-8. PubMed ID: 16266057 [Abstract] [Full Text] [Related]
8. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. Kolias AG, Sen J, Belli A. J Neurosci Res; 2009 Jan; 87(1):1-11. PubMed ID: 18709660 [Abstract] [Full Text] [Related]
9. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Findlay JM, Macdonald RL, Weir BK. Cerebrovasc Brain Metab Rev; 1991 Jan; 3(4):336-61. PubMed ID: 1772740 [Abstract] [Full Text] [Related]
11. Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage. Momin EN, Schwab KE, Chaichana KL, Miller-Lotan R, Levy AP, Tamargo RJ. Neurosurgery; 2009 Nov; 65(5):937-45; discussion 945. PubMed ID: 19834407 [Abstract] [Full Text] [Related]
12. A hypothesis on possible neurochemical mechanisms of action of cervical spinal cord stimulation in prevention and treatment of cerebral arterial vasospasm after aneurysmal subarachnoid hemorrhage. Yin D, Slavin KV. Med Hypotheses; 2015 Sep; 85(3):355-8. PubMed ID: 26141634 [Abstract] [Full Text] [Related]
13. Nitric oxide in subarachnoid haemorrhage and its therapeutics implications. Hänggi D, Steiger HJ. Acta Neurochir (Wien); 2006 Jun; 148(6):605-13; discussion 613. PubMed ID: 16541208 [Abstract] [Full Text] [Related]
14. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N. Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244 [Abstract] [Full Text] [Related]